Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.92 USD | -3.03% |
|
-9.43% | +10.35% |
Jun. 27 | BioRestorative Therapies, Inc. Announces Notice of Allowance for Patent Covering Fundamental Aspect of ThermoStem® Metabolic Disease Program | CI |
Jun. 13 | Top Midday Gainers | MT |
Chart calendar BioRestorative Therapies, Inc.
Upcoming events on BioRestorative Therapies, Inc.
No events available
Past events on BioRestorative Therapies, Inc.
2024-05-14 04:30 pm | Q1 2024 Earnings Call |
2024-05-14 04:10 pm | Q1 2024 Earnings Release |
2024-03-18 03:00 pm | Roth Conference |
2024-02-05 08:30 am | BRTX-100 Phase 2 Clinical Trial Results Call |
2024-02-04 01:15 pm | Orthopaedic Research Society Meeting |
2023-10-14 09:00 am | ROTH MKM Healthcare Opportunities Conference |
2023-09-13 10:00 am | Annual General Meeting |
2023-06-22 09:30 am | Maxim Group Virtual Healthcare Conference |
2023-06-06 | Jefferies Global Healthcare Conference |
2023-05-09 | EF Hutton Global Conference |
2023-03-11 | Roth Conference |
2023-01-26 10:30 am | Q1 Investor Summit |
2022-12-05 10:00 am | RHK Capital Disruptive Growth Conference |
2022-10-11 | Dawson James Small Cap Growth Conference |
2022-10-05 | Roth Healthcare Opportunities Conference |
2022-09-14 11:30 am | H.C. Wainwright Global Investment Conference |
2022-01-10 07:00 am | H.C. Wainwright BioConnect Conference - Pre-Recorded |
2021-08-17 10:00 am | Annual General Meeting |
2021-06-09 10:45 am | The Emerging Growth Conference |
2018-05-15 05:49 pm | Q1 2018 Earnings Release |
Annual results
Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,08 | 0,05 0,04 12.2% | 0,12 0,13 -8.55% | 0,15 0,14 2.68% | 0,58 |
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | 0,00 | -26,3 -24,2 -8.72% | -19,0 -19,3 1.52% | -15,2 -15,3 0.28% | -18,6 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -44,3 -24,0 -84.6% | -18,5 -19,1 3.28% | -14,4 -14,8 2.62% | -16,6 |
Net income Million USD | Released Forecast Spread | 0,00 | -44,3 -25,8 -71.72% | -18,5 -19,1 3.28% | -14,4 -14,8 2.62% | -16,6 |
EPS USD | Released Forecast Spread | -0,01 | -37,3 -5,54 -573.29% | -5,11 -5,28 3.22% | -3,42 -3,52 2.84% | -2,06 |
Announcement Date | 30/04/21 | 30/03/22 | 27/03/23 | 01/04/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,02 0,00 - | 0,03 0,00 - | 0,00 0,02 -75.33% | 0,03 0,03 4.33% | 0,06 0,02 330% | 0,03 0,02 104.67% | 0,02 0,02 28.67% | 0,04 0,02 133.33% | 0,02 | 0,22 | 0,32 | 0,52 | 0,54 |
EBIT Million USD | Released Forecast Spread | -5,05 -2,25 -124.61% | -4,61 -5,27 12.58% | -4,68 -4,97 5.87% | -5,78 -4,83 -19.75% | -3,12 -5,95 47.63% | -3,10 -3,27 5.06% | -3,22 -3,26 1.3% | -4,11 -3,88 -5.81% | -4,51 | -4,78 | -5,19 | ||
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -4,66 -5,27 11.7% | -4,35 -4,97 12.59% | -5,68 -4,73 -20.28% | -2,98 -5,90 49.49% | -2,93 -3,17 7.71% | -2,83 -3,21 12.07% | -2,22 -3,83 42% | -4,46 | -4,73 | -5,14 | |||
Net income Million USD | Released Forecast Spread | -4,82 -2,25 -114.05% | -4,66 -5,27 11.7% | -4,35 -4,97 12.59% | -5,68 -4,73 -20.28% | -2,98 -5,90 49.49% | -2,93 -3,17 7.71% | -2,83 -3,21 12.07% | -2,22 -3,83 42% | -4,46 | -4,73 | -5,14 | ||
EPS USD | Released Forecast Spread | -1,37 -0,63 -117.46% | -1,28 -1,45 11.72% | -1,18 -1,35 12.59% | -1,53 -1,26 -21.43% | -0,77 -1,19 35.29% | -0,64 -0,68 5.88% | -0,57 -0,69 17.39% | -0,33 -0,52 36.54% | -0,55 | -0,58 | -0,56 | ||
Announcement Date | 16/05/22 | 14/11/22 | 27/03/23 | 12/05/23 | 11/08/23 | 13/11/23 | 01/04/24 | 11/06/24 | - | - | - | - | - |
Past sector events for BioRestorative Therapies, Inc.
2024-06-05 03:51 am | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 04:00 pm | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BRTX Stock
- Calendar BioRestorative Therapies, Inc.